Literature DB >> 15707260

Antecedents to effective treatment of hypertension in Hispanic populations.

Maria L Soto-Greene1, Debbie Salas-Lopez, Jorge Sanchez, Robert C Like.   

Abstract

Hypertension is a common medical disorder affecting >50 million people. It is a primary modifiable risk factor to cardiovascular disease and a leading cause of death in black and Hispanic groups. This article focuses on patient-specific and physician-specific barriers that contribute to underdiagnosis, undertreatment, access issues, and poor adherence to therapy. Two cross-cultural interviewing frameworks, ETHNIC and ADHERE, are discussed as approaches that complement the traditional clinical assessment and treatment of hypertension in Hispanics.

Entities:  

Mesh:

Year:  2004        PMID: 15707260     DOI: 10.1016/s1098-3597(04)80062-0

Source DB:  PubMed          Journal:  Clin Cornerstone        ISSN: 1873-4480


  3 in total

1.  Prevalence and incident prehypertension and hypertension in postmenopausal Hispanic women: results from the Women's Health Initiative.

Authors:  Ruth E Zambrana; Lenny López; Gniesha Y Dinwiddie; Roberta M Ray; Lawrence S Phillips; Maurizio Trevisan; Sylvia Wassertheil-Smoller
Journal:  Am J Hypertens       Date:  2014-01-30       Impact factor: 2.689

2.  Effectiveness and sustainability of a structured group-based educational program (MEDIHEALTH) in improving medication adherence among Malay patients with underlying type 2 diabetes mellitus in Sarawak State of Malaysia: study protocol of a randomized controlled trial.

Authors:  Chuo Yew Ting; Shahren Ahmad Zaidi Adruce; Mohamed Azmi Hassali; Hiram Ting; Chien Joo Lim; Rachel Sing-Kiat Ting; Abu Hassan Alshaari Abd Jabar; Nor Anizah Osman; Izzul Syazwan Shuib; Shing Chyi Loo; Sui Theng Sim; Su Ee Lim; Donald E Morisky
Journal:  Trials       Date:  2018-06-05       Impact factor: 2.279

Review 3.  Poor Medication Adherence in African Americans Is a Matter of Trust.

Authors:  Gregory L Hall; Michele Heath
Journal:  J Racial Ethn Health Disparities       Date:  2020-11-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.